Carbon Therapy Segment in Particle Therapy Market to Grow at Exponential Growth Rate from 2018 to 2026: TMR

- Brain and spinal cord tumors, pediatric cancer segments are contributing notably to growth in the particle therapy market over the forecast period

- North America is witnessing significant increase in cases of brain and spinal cord tumor and that is helping the region account for a notable share of the market

ALBANY, N.Y., Sept. 17, 2020 /PRNewswire/ -- From 2018 to 2026, the compound annual growth rate (CAGR) of global particle therapy market is anticipated to be 8%. It is worth noting here that numerous reasons are seen behind the projected growth, which is set to translate to a higher market worth of USD 727 million by the year 2026 – the end of the aforementioned period. In the year 2017, it is quite pertinent to note, the market valuation stood at USD 364.8 million.

"Incidence of lung cancer in young population, brain and spine tumors in geriatric population is increasing and that is propelling growth in the global particle therapy market over the forecast period", notes TMR

Request for Analysis of COVID-19 Impact on Particle Therapy Market – https://www.transparencymarketresearch.com/covid19.php

Key Findings of Global Particle Therapy Market Study

• As far as applications are concerned, pediatric cancer, and brain and spinal cord tumors will dominate growth in the segment
• In the therapy segment, proton therapy held a notable share of the market and the trend is expected to continue over the forecast period
• North America is set to lead the regional charts, while the Asia Pacific region is set to grow at a notable pace

For a detailed analysis of global particle therapy market by therapy, cancer application, services end-user, region, and visit TOC https://www.transparencymarketresearch.com/report-toc/56133

Key Drivers of Growth in Global Particle Therapy Market:

• Increasing adoption of pain free treatment is being noted and this is paving way for growth in the market
• Number of geriatric people with brain and spine tumors is increasing, propelling the global particle therapy market on an upward curve
• Increasing cyclotron service practices noted in countries such as the United States of America is a notable growth factor

Regional Analysis of Global Particle Therapy Market:

• Growing geriatric population with brain tumor and spine tumor is being noted in the North American region
• These factors are set to drive the aforementioned region on to a dominant position over the forecast period
• Contributions of the United States of America towards growth in the region are anticipated to be significant owing to increasing incidence of lung cancer among youth
• The country is also witnessing  increase in cyclotron services practices and that is propelling growth in the regional therapy market
• Notable CAGR will be charted by the Asia Pacific (APAC) region, where Japan and China will be at the forefront of growth

Analyze global particle therapy market growth in 30+ countries including US, Canada, Germany, United Kingdom, France, Italy, Russia, Poland, Benelux, Nordic, China, Japan, India, and South Korea. Request a sample of the study https://www.transparencymarketresearch.com/sample.php

Competitive Landscape of Global Particle Therapy Market:

The vendor landscape is marked by growth strategies that are shaping the future dynamics of the market. Some of these include proactive measures – organic and inorganic – opted for by leading players. These comprise collaborations and acquisitions, and improvement in geographic reach.

Purchase the Particle Therapy Market Report - https://www.transparencymarketresearch.com/checkout.php

Key players in the global particle therapy market are Varian Medical Systems, Inc., Hitachi, Ltd., IBA Worldwide, and Sumitomo Heavy Industries, Ltd., Advanced Oncotherapy PLC., Mevion Medical Systems, Inc., Provision Healthcare, LLC, Optivus Proton Therapy, Inc., Protom International, Inc., and Danfysik A/S. Of these, Varian Medical Systems, Inc., Hitachi, Ltd., IBA Worldwide, and Sumitomo Heavy Industries, Ltd. hold a sizeable share of the market. In its report, Transparency Market Research has covered granular information on these players. A part of this information is details into financials, recent developments and growth strategies.

Browse More Press Release - https://www.transparencymarketresearch.com/press-releases.htm

For the study, the Particle Therapy market has been segmented as follows: 

Therapy

• Particle Therapy
• Carbon Therapy
• Other Therapy 

Cancer Application

• Pediatric Cancer
• Lung Cancer
• Bladder Cancer
• Brain and Spinal Cord Tumors (BSCT)
• Breast Cancer
• Gastrointestinal (GI) Cancers
• Hepatocellular Carcinoma (HCC)
• Head and Neck Cancers (HNC) 

Services

• Cyclotrons
• Synchrotrons
• Synchrocyclotrons 

End user

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers 

Explore Transparency Market Research's award-winning coverage of the global Healthcare Industry:

Autologous Cell Therapy Market: According to the report, the global autologous cell therapy market was valued at US$ 7.5 Bn in 2018 and is anticipated to expand at a CAGR of 18.1% from 2019 to 2027, rise in prevalence of autoimmune disorders, cancer, blood related disorders, are projected to drive the global market during the forecast period

Compression Therapy Market: According to the report, the global compression therapy market was valued at US$ 3.2 Bn in 2018 and is anticipated to expand at a CAGR of 6.1% from 2019 to 2027, owing to rising sports injuries, increase in the number of orthopedic surgeries, and rapidly growing obese population boost demand for compression therapy products globally

Liposome Drug Delivery Market: Companies in the liposome drug delivery market are increasing their focus on drug delivery nanosystems involving major antiviral classes and their transport across specific barriers at cellular and intracellular levels. Thus, liposomes hold promising potentials in ongoing research studies being carried out by healthcare companies for the treatment of coronavirus

Browse Our Latest Reports - https://www.transparencymarketresearch.com/latest.htm

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision."

Browse More Upcoming Reports by Transparency Market Research: https://www.transparencymarketresearch.com/upcoming.htm

Contact

Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: [email protected] 
Press Release Source: https://www.transparencymarketresearch.com/pressrelease/particle-therapy-market.htm 
Website: https://www.transparencymarketresearch.com/ 

Logo: https://mma.prnewswire.com/media/1085206/Transparency_Market_Research_Logo.jpg